BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 29298778)

  • 1.
    Carnt N; Robaei D; Minassian DC; Dart JKG
    Br J Ophthalmol; 2018 Oct; 102(10):1431-1435. PubMed ID: 29298778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Topical Corticosteroids Used in Conjunction with Antiamoebic Therapy on the Outcome of Acanthamoeba Keratitis.
    Carnt N; Robaei D; Watson SL; Minassian DC; Dart JK
    Ophthalmology; 2016 May; 123(5):984-90. PubMed ID: 26952591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rising tide of Acanthamoeba keratitis in Auckland, New Zealand: a 7-year review of presentation, diagnosis and outcomes (2009-2016).
    McKelvie J; Alshiakhi M; Ziaei M; Patel DV; McGhee CN
    Clin Exp Ophthalmol; 2018 Aug; 46(6):600-607. PubMed ID: 29412494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of topical corticosteroid use before diagnosis on the outcome of Acanthamoeba keratitis.
    Robaei D; Carnt N; Minassian DC; Dart JK
    Ophthalmology; 2014 Jul; 121(7):1383-8. PubMed ID: 24630688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed diagnoses of Acanthamoeba keratitis at a tertiary care medical centre.
    Shah YS; Stroh IG; Zafar S; Zhang N; Sriparna M; Shekhawat N; Ghos Z; Srikumaran D; Woreta FA
    Acta Ophthalmol; 2021 Dec; 99(8):916-921. PubMed ID: 33583148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acanthamoeba sclerokeratitis: epidemiology, clinical features, and treatment outcomes.
    Iovieno A; Gore DM; Carnt N; Dart JK
    Ophthalmology; 2014 Dec; 121(12):2340-7. PubMed ID: 25097155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with Acanthamoeba keratitis at the cole eye institute, 1999-2008.
    Qian Y; Meisler DM; Langston RH; Jeng BH
    Cornea; 2010 Sep; 29(9):1016-21. PubMed ID: 20539213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-year review of Acanthamoeba keratitis in New South Wales, Australia: 1997-2002.
    Butler TK; Males JJ; Robinson LP; Wechsler AW; Sutton GL; Cheng J; Taylor P; McClellan K
    Clin Exp Ophthalmol; 2005 Feb; 33(1):41-6. PubMed ID: 15670077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Analysis of Depth, Distribution, and Density of Cysts in Acanthamoeba Keratitis Using Confocal Microscopy.
    Huang P; Tepelus T; Vickers LA; Baghdasaryan E; Huang J; Irvine JA; Hsu HY; Sadda S; Lee OL
    Cornea; 2017 Aug; 36(8):927-932. PubMed ID: 28542085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes and prognostic factors associated with acanthamoeba keratitis.
    Chew HF; Yildiz EH; Hammersmith KM; Eagle RC; Rapuano CJ; Laibson PR; Ayres BD; Jin YP; Cohen EJ
    Cornea; 2011 Apr; 30(4):435-41. PubMed ID: 21045665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acanthamoeba keratitis: a parasite on the rise.
    Thebpatiphat N; Hammersmith KM; Rocha FN; Rapuano CJ; Ayres BD; Laibson PR; Eagle RC; Cohen EJ
    Cornea; 2007 Jul; 26(6):701-6. PubMed ID: 17592320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acanthamoeba keratitis associated with contact lens wear in Singapore.
    Por YM; Mehta JS; Chua JL; Koh TH; Khor WB; Fong AC; Lim JW; Heng WJ; Loh RS; Lim L; Tan DT
    Am J Ophthalmol; 2009 Jul; 148(1):7-12.e2. PubMed ID: 19403109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical experience of Acanthamoeba keratitis at a tertiary care eye hospital.
    Tanhehco T; Colby K
    Cornea; 2010 Sep; 29(9):1005-10. PubMed ID: 20539211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors affecting visual outcome in Acanthamoeba keratitis.
    Tu EY; Joslin CE; Sugar J; Shoff ME; Booton GC
    Ophthalmology; 2008 Nov; 115(11):1998-2003. PubMed ID: 18571729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resurgence of Acanthamoeba keratitis in Auckland, New Zealand: a 7-year review of presentation and outcomes.
    Patel DV; Rayner S; McGhee CN
    Clin Exp Ophthalmol; 2010 Jan; 38(1):15-20; quiz 87. PubMed ID: 20447096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors, demographics and clinical profile of
    Lee MH; Abell RG; Mitra B; Ferdinands M; Vajpayee RB
    Br J Ophthalmol; 2018 May; 102(5):687-691. PubMed ID: 28844988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors associated with the need for surgical treatments in acanthamoeba keratitis.
    Bouheraoua N; Gaujoux T; Goldschmidt P; Chaumeil C; Laroche L; Borderie VM
    Cornea; 2013 Feb; 32(2):130-6. PubMed ID: 23132441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Penetrating Keratoplasty À Chaud May Improve Outcome in Therapy-Resistant Acanthamoeba Keratitis.
    Laurik KL; Szentmáry N; Daas L; Langenbucher A; Seitz B
    Adv Ther; 2019 Sep; 36(9):2528-2540. PubMed ID: 31317392
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Papa V; Rama P; Radford C; Minassian DC; Dart JKG
    Br J Ophthalmol; 2020 Apr; 104(4):575-581. PubMed ID: 31401556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acanthamoeba keratitis: 10-year study at a tertiary eye care center in Hong Kong.
    Chin J; Young AL; Hui M; Jhanji V
    Cont Lens Anterior Eye; 2015 Apr; 38(2):99-103. PubMed ID: 25496910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.